Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1

Details for Australian Patent Application No. 2002364727 (hide)

Owner Repair, Inc. Maine Medical Center Research Institute

Inventors Burgess, Wilson H; Ettenson, David S; Drohan, William N; Maciag, Thomas

Agent Fisher Adams Kelly

Pub. Number AU-B-2002364727

PCT Number PCT/US02/39686

PCT Pub. Number WO2003/052378

Priority 10/022,554 17.12.01 US

Filing date 11 December 2002

Wipo publication date 30 June 2003

Acceptance publication date 21 September 2006

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 10/022,554 17.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002364727

21 September 2006 Application Accepted

  Published as AU-B-2002364727

18 January 2007 Standard Patent Sealed

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364728-METHOD FOR MR/NMR IMAGING

2002364726-PHOTOMASK AND METHOD FOR QUALIFYING THE SAME WITH A PROTOTYPE SPECIFICATION